Shots:
Leonard spoke about how Lilly is advancing in the field of metabolic disease research (esp. diabetes)
He also talked about its lead candidate in type 2 diabetes and also discussed its clinical results in detail
The interview summarizes Lilly’s objective to advance new discoveries and redefine diabetes care
Smriti: Tell us how Lilly is leading…
